IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) CEO Bram Goorden talked with Proactiv's Stephen Gunnion about the company’s new collaboration with Medidata and how it supports IXICO’s growth strategy in the clinical trials space. Goorden described the agreement as a significant milestone, highlighting Medidata’s position as “a multibillion dollar player in the clinical trial space” with a global footprint across thousands of trials. The partnership combines Medidata’s electronic data capture and clinical trial t ...